FeesSafety
Pluang+

Ituran Location & Control shows strong growth with high dividend yield and attractive valuation.

Analyst Insights
03 Nov 2026, 11:47 WIB
Seeking Alpha
View Source
Bullish
Ituran Location & Control shows strong growth with high dividend yield and attractive valuation.

Ituran Location & Control (ITRN), a leader in mobility technology in Israel and Latin America, has outperformed many tech stocks and small caps over the past year. The company is expected to improve its subscription growth in the second half of the year and is entering a significant multi-year big data opportunity. With a record free cash flow margin of 21.4%, Ituran supports a 5.72% dividend yield and has resumed share buybacks. Its valuation appears attractive with a forward P/E of 13.1x and projected medium-term EPS growth of 17%, making it a compelling option for investors seeking dividend-focused tech stocks.

For readers following Ituran Location & Control, here is Pluang's market snapshot as of Nov 03, 2026 16:11 WIB: Among 150 priced Technology-sector US stocks tradable on Pluang, 80 rose and 69 fell today. ASX traded at USD 37.98 with a 1-day change of -3.04%, EGHT was priced at USD 2.02 with a 1-day change of -2.88%, and NBIS closed at USD 145.44 with a 1-day change of +2.86%.

More News

Anavex names Terrie Kellmeyer CEO to lead clinical growth and FDA engagement

Anavex names Terrie Kellmeyer CEO to lead clinical growth and FDA engagement

Anavex Life Sciences appointed Terrie Kellmeyer, Ph.D., as President and CEO, also joining the Board. Kellmeyer, with over 30 years in biopharma, has led the company through key clinical milestones including FDA clearance for Fragile X syndrome trial...

Company Fundamentals
Bullish
45 minutes ago
Cardiff Oncology to present at UBS Global Biopharma Conference on Nov 16-17, 2026

Cardiff Oncology to present at UBS Global Biopharma Conference on Nov 16-17, 2026

Cardiff Oncology, a clinical-stage biotech company focusing on cancer therapies via PLK1 inhibition, announced it will present at the UBS Global Biopharma Conference on November 16-17, 2026. The company's CEO, Mani Mohindru, will deliver a fireside c...

Market News
Bullish
45 minutes ago
Seyond expands smart city tech with LiDAR-powered operational twins and AI collaborations

Seyond expands smart city tech with LiDAR-powered operational twins and AI collaborations

Seyond Inc is enhancing its smart city solutions by integrating advanced LiDAR 3D sensing with AI-powered analytics and collaborations with Dell Technologies, NVIDIA, and AMSYS. This expansion supports improved safety, transportation, and infrastruct...

Market News
Bullish
45 minutes ago
Stella-Jones schedules Q3 2026 earnings call for Nov 4, open to investors and analysts.

Stella-Jones schedules Q3 2026 earnings call for Nov 4, open to investors and analysts.

Stella-Jones Inc. announced a teleconference on November 4, 2026, at 10:00 AM EST to discuss its third-quarter 2026 financial results. The event is open to investors, analysts, and interested parties, with live streaming and phone access provided. A ...

Company Fundamentals
Neutral
1 hour ago
Stella-Jones to hold Q3 2026 financial results conference call on Nov 4

Stella-Jones to hold Q3 2026 financial results conference call on Nov 4

Stella-Jones Inc. announced a conference call for November 4, 2026, at 10:00 AM EST to discuss its third quarter 2026 financial results. The call is open to investors, analysts, and interested parties and will be webcast live with a recording availab...

Company Fundamentals
Neutral
1 hour ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App